Skip to main content
ACS Omega logoLink to ACS Omega
. 2023 Jul 14;8(29):26590–26596. doi: 10.1021/acsomega.3c03512

Genetic Encoding of Arylazopyrazole Phenylalanine for Optical Control of Translation

Chasity P Janosko , Olivia Shade , Taylor M Courtney , Trevor J Horst , Melinda Liu , Sagar D Khare , Alexander Deiters †,*
PMCID: PMC10373180  PMID: 37521667

Abstract

graphic file with name ao3c03512_0008.jpg

An arylazopyrazole was explored for its use as an enhanced photoswitchable amino acid in genetic code expansion. This new unnatural amino acid was successfully incorporated into proteins in both bacterial and mammalian cells. While photocontrol of translation required pulsed irradiations, complete selectivity for the trans-configuration by the pyrrolysyl tRNA synthetase was observed, demonstrating expression of a gene of interest selectively controlled via light exposure.

Introduction

Optogenetics, or the genetic encoding of light-controlled proteins, allows for non-invasive investigation of biological processes with precise spatiotemporal control.1 Light-responsive proteins, such as phytochrome and cytochrome photoreceptors, have been used to investigate signaling pathways,2,3 transcription,4,5 and protein localization.68 While light-responsive protein domains can enable precise spatiotemporal control of the specified system, a protein fusion is always needed. Conversely, photocaged proteins, or proteins bearing a photolabile moiety that blocks a specified function before cleavage and activation with light,9 require only a point mutation for the introduction of an unnatural amino acid (UAA) while still maintaining precise optical control. Photocaged proteins are useful for investigating certain biological systems, but the irreversible nature of caging group removal prevents extended control of the system. Instead, reversible control of biological function is a powerful tool as it enables persistent and precise spatiotemporal control.10 Photoswitchable molecules use light to induce isomerization and alter protein function, and they have become a valuable alternative to photocaged systems when prolonged protein control is needed.

Genetic code expansion is one of several optogenetic approaches to placing protein function under light control.1114 The genetic incorporation of a UAA is enabled by an orthogonal aminoacyl-tRNA synthetase and tRNA that recognize and suppress an amber stop codon to incorporate the UAA.15 Further, the Methanosarcina mazei, Methanosarcina barkeri, or Methanomethylophilus alvus pyrrolysyl-tRNA synthetase/tRNACUA (PylRS/PylT) pairs are favored as their tRNAs are natural amber suppressors and the pairs are orthogonal in both mammalian and Escherichia coli cells.1518 The PylRS/PylT pair has been engineered to encode over 100 UAAs, providing a range of new chemical structures and new functionalities to proteins.19 With precise site specificity, genetic code expansion has found numerous applications in protein modification.20,21

Azobenzene-derived photoswitchable UAAs, the first being azobenzene phenylalanine (AzoF), have been genetically encoded and used to control DNA binding22 and the function of fluorescent proteins.23 Additionally, two fluorinated analogs of AzoF were shown to reversibly control the function of a luminescent protein,24 and photoswitchable Cys-reactive amino acids have been used to control protein function through alteration of protein conformation.25,26 Although current tools show the ability to photoswitch in a cellular environment and, in some cases, provide reversible control of protein function, the photostationary states (PSS) of these chromophores are not ideal. For example, AzoF irradiated with 365 nm light leads to a PSS of 78% cis, and irradiation with 450 nm light yields a PSS of 76% trans. Additionally, the thermal stability of cis-AzoF is limited to ∼13 h.27 The incomplete isomerization at each wavelength and the stability of the cis-isomer allow ample space for improvement,22 as an ideal photoswitch would undergo quantitative isomerization to the specified configuration. Fluorinated analogs of AzoF showed enhanced trans-to-cis PSS but remained inefficient in returning to the trans-configuration upon irradiation with different wavelengths.24

In addition to the azobenzene core utilized in AzoF, other azo-containing heterocycles have been developed to improve photochemical properties of the azo-functionality. Small chromophores containing aryl-azo groups linked to imidazole,28 indazole,29 triazole, pyrazole, pyrrole, and tetrazole30 have been developed to further improve the PSS of this class of photoswitches. Namely, an arylazopyrazole derivative presented near-complete photoswitching properties, with a PSS of 98% cis and 98% trans when irradiated with 355 and 532 nm light, respectively.30 Despite the improved photoswitching capabilities of azo-heterocyclic chromophores, UAAs bearing these functional groups have yet to be employed in the photocontrol of proteins or peptides.

In designing UAAs for photoswitchable control of protein function, the size of the photoswitch also needs to be considered. In contrast to other photoswitchable motifs,31 azobenzenes and azo-heterocycles are relatively small, which facilitates recognition by a tRNA synthetase.32 We hypothesized that an arylazopyrazole-modified phenylalanine (AAPF) would show improved photophysical properties as compared to its azobenzene predecessors while maintaining the ability to be genetically encoded.

Results and Discussion

Synthesis of an Arylazopyrazole-Modified Phenylalanine

The photoswitchable AAPF was synthesized in two steps (Figure 1A) from the commercially available Fmoc-4-aminophenylalanine (1). First, the para-amine was converted to the corresponding diazonium salt, followed by immediate enolate addition to form hydrazone 2 in 60% yield.33,34 Methyl hydrazine was then utilized in both the formation of the pyrazole moiety and cleavage of the Fmoc protecting group, yielding the final product AAPF in 68% yield. To improve solubility for biological assays, AAPF was then converted to the corresponding HCl salt.

Figure 1.

Figure 1

Synthesis and photochemical analysis of AAPF. (A) Synthesis of AAPF. (B) Irradiation of AAPF with 365 and 530 nm light converts the trans-isomer to the cis-isomer and back, respectively. (C) Absorbance spectra and (D) HPLC chromatograms (absorbance at 280 nm) of both isomers (250 μM in PBS, 2.5% DMSO) show near-complete photoswitching. (E, F) Photostationary states and extinction coefficients of AAPF after 10 min of irradiation at either 530 or 365 nm. (G) Repeat photoswitching of AAPF as measured by HPLC.

Determination of Photostationary States

Prior to using AAPF in cell-based assays, we sought to confirm its ability to act as an efficient photoswitch. Based on the photoswitching properties of the corresponding 3′,5′-dimethylated arylazopyrazole,30 we hypothesized that irradiation with 365 nm light would provide the cis-isomer of AAPF, whereas irradiation with 530 nm light would provide the trans-isomer (Figure 1B). Solutions of AAPF (250 μM) were prepared in phosphate-buffered saline (PBS) and irradiated with either 365 nm (UV transilluminator, 10 min) or 530 nm (LED, 10 min) light. The samples were then analyzed via absorbance scan and HPLC.

The absorbance spectrum of trans-AAPF shows the two absorbance maxima characteristic of arylazo compounds,31 with the highest extinction coefficient near 340 nm corresponding to the symmetry-allowed π–π* transition and a smaller peak maximum near 430 nm corresponding to the symmetry-forbidden n−π* transition (Figure 1C). Upon irradiation with 365 nm light, the absorbance spectrum of AAPF shows a decrease in the π–π* absorption and an increase in the n−π* absorption, indicating isomerization from the trans- to the cis-isomer (Figure 1C). To quantify each photostationary state, samples were analyzed via HPLC. Two distinct peaks were observed at 6.0 and 7.9 min, corresponding to the cis- and trans-isomers, respectively. Integration of each peak area revealed near-complete photoswitching, with 96% of trans-AAPF after irradiation with 530 nm light and 91% of cis-AAPF after irradiation with 365 nm light (Figure 1D,E). The molar extinction coefficient of AAPF was calculated by measuring the absorbance of 1 mM AAPF (irradiated with either 530 or 365 nm for the trans and cis states, respectively) at both of the local absorbance maxima, 436 and 340 nm (Figure 1F). Further, the reversibility of AAPF was validated with sequential irradiations at 530 and 365 nm and yielded consistent isomerization between the trans- and cis-isomers, respectively, as quantified by HPLC (Figure 1G). Efficient and reversible photoswitching of AAPF is observed by the distinct changes in the absorbance spectra and HPLC chromatograms, making AAPF the most efficient photoswitchable UAA to date.22,24

Incorporation of AAPF into Protein in E. coli

After successful demonstration of photoswitching, the incorporation of AAPF into proteins in bacterial cells was explored. To encode AAPF, a two-plasmid system was utilized (Figure 2A). One plasmid encodes both the gene of interest, in this case, sfGFP with an amber stop codon (TAG) at position Y151, and the pyrrolysyl tRNA (PylT). The second plasmid encodes a mutant of the M. barkeri pyrrolysyl synthetase (PylRS). To select a synthetase for optimal AAPF incorporation, a small panel of 13 PylRS mutants was screened (Table S1). Expression of the fluorescent protein sfGFP was determined for each individual culture via fluorescence intensity, which was then normalized to the absorbance at 600 nm to account for any culture-to-culture variation in the number of cells collected (Figure S1). From this synthetase screen, two potential hits were identified due to the high level of AAPF incorporated relative to background gene expression: PylRS-16-5 and PylRS-20.

Figure 2.

Figure 2

Incorporation of AAPF into protein in E. coli. (A) Two-plasmid system utilized for genetic encoding of AAPF in bacterial cells. (B) Expression and purification of sfGFP in the presence and absence of AAPF using PylRS-16-5 and PylRS-20 (AzoFRS2) analyzed via SDS-PAGE and visualized using Coomassie stain.

These two hits were further analyzed by performing larger scale expressions of sfGFP-Y151AAPF with either PylRS-16-5 or PylRS-20. His-tagged sfGFP-Y151AAPF was isolated, and expression levels were analyzed by SDS-PAGE (Figure 2B). PylRS-16-5 showed high background incorporation in the absence of AAPF, which was confirmed by mass spectrometry. In contrast, high levels of sfGFP-Y151AAPF were observed with PylRS-20 and only low background incorporation of endogenous phenylalanine, as confirmed by mass spectrometry (Figure S2). PylRS-20 has previously been named AzoFRS2 for its ability to encode azobenzene analogs,24 and thus, it is not surprising that it was also able to accept AAPF as a substrate.

Incorporation of AAPF into Protein in Mammalian Cells

We also tested incorporation of AAPF in mammalian cells. HEK293T cells were transfected with a two-plasmid system similar to that used in the bacterial experiments above.15 The first plasmid encodes an mCherry-EGFP fusion protein, designed such that the TAG stop codon is located between the two fluorescent proteins, yielding pmCherry-TAG-EGFP-HA. With this placement of the stop codon, mCherry is constitutively expressed and serves as an internal control for transfection, whereas EGFP is only expressed if AAPF incorporation is successful. The second plasmid encodes both the PylRS, in this case, the mammalian codon-optimized AzoFRS2, and four copies of the corresponding PylT (Figure 3A).

Figure 3.

Figure 3

Incorporation of AAPF in HEK293T cells. (A) Schematic of the two-plasmid system utilized for incorporation of AAPF into mammalian cells. (B) HEK293T cells were analyzed for green fluorescence from EGFP expression. The scale bar is equal to 50 μm. (C) Western blot analysis of cells transfected with pmCherry-TAG-EGFP-HA in the presence or absence of AAPF.

Fluorescence microscopy was used to validate the incorporation of AAPF into pmCherry-TAG-EGFP-HA expressed in mammalian cells (Figure 3B). HEK293T cells were transfected with the necessary plasmids in the presence or absence of AAPF (250 μM). Following a 24 h incubation, the cells were washed with live cell imaging solution and imaged for EGFP (ex. 470/40, em. 525/50 nm) and mCherry (ex. 550/25, em. 605/70 nm) fluorescence using a Zeiss fluorescence microscope. Imaging revealed EGFP fluorescence in the presence of AAPF, showing efficient incorporation of the UAA and expression of the full-length protein (Figure 3B).

To further validate the live cell imaging result, mammalian cells expressing mCherry-AAPF-EGFP-HA were lysed and analyzed via western blot (Figure 3C). With the placement of a C-terminal HA-tag on pmCherry-AAPF-EGFP, the anti-HA western blot confirms the expression of the full-length protein. Expression of the reporter was observed in the presence of AAPF, confirming successful incorporation of AAPF in mammalian cells using AzoFRS2. Some full-length protein was detected even in the absence of AAPF, which correlates well with the small amount of background observed in bacterial expressions (Figure 2B). Western blot and fluorescence microscopy both demonstrate clear incorporation of AAPF over background through detection of the full-length mCherry-AAPF-EGFP construct.

Optical Control of Translation through Photoswitching of AAPF

Control of translation has been previously demonstrated using chemically modified tRNA and mRNA. Caged tRNAs have been used in the light activation of translation in cell-free systems and in mammalian cells;35,36 however, chemically acylated tRNAs have limited stability (<4 h) and hydrolyze readily.36 Photocaged mRNAs have been generated through enzymatic placement of photocaging groups in the 5′-UTR37 or the 5′-cap,38 which allowed for efficient optical control of translation in mammalian cells. Furthermore, photoswitchable chromophores integrated into the 5′-cap enabled reversible light activation of translation in cells39 and zebrafish embryos.40 While these approaches utilize innovative designs, they are limited by the short half-life of synthetic mRNA, which is estimated to range from only a few minutes to ∼9 h in mammalian cells and 4 to 5 h in zebrafish.4143 We hypothesized that optical control of UAA recognition would address long-term stability concerns due to the intracellular production of mRNA and tRNA through transcription, thus providing a novel means for light-controlled protein expression. The underlying concept is the strong preference of an engineered amino-acyl synthetase to recognize only one configuration of a photoswitchable UAA as a substrate.

To investigate the feasibility of each AAPF isomer to be a substrate for AzoFRS2 (PDB: 4ZIB),44 computational modeling was performed using PyRosetta. First, AzoFRS2 binding site models were generated with adenosine triphosphate (ATP), three magnesium ions, a coordinating water molecule, and either isomer of AAPF. The total energies and computed pocket energies were then used to evaluate the feasibility of the AAPF isomer binding to the AzoFRS2 active site.45 To generate catalytically active models, a near-attack geometry was constrained between the UAA and the ATP. Per-residue energy decomposition revealed several interactions that are more stable when AzoFRS2 is docked with trans-AAPF than with cis-AAPF. When AAPF was in the cis configuration, the pyrazole moiety clashed with F349 of AzoFRS2, thus forcing rotation and increasing its energy by 3.93 Rosetta Energy Units (REU) (Figure 4A). Residue G313 has a favorable interaction with trans-AAPF, which was lost in the cis configuration, thus causing a difference of 1.72 REU (Figure 4B). Both isomers of AAPF lead to a rotameric change in W382 when compared to the apo model, but cis-AAPF disrupted it by 1.53 REU more than the trans-AAPF. This disruption further impacted G368 by an additional 1.18 REU for cis-AAPF compared to trans-AAPF (Figure 4C). Other residues that contributed to a more stable AzoFRS2 active site with trans-AAPF rather than with cis-AAPF include F270 and Y271 (Figure 4D). Overall, the energies observed upon binding of trans-AAPF were 11 REU lower than the energies corresponding to cis-AAPF binding, with 10 REU of the energy differential occurring within the binding pocket, indicating that trans-AAPF should be strongly favored by AzoFRS2 (Table S2). With the computational evidence suggesting that AzoFRS2 favors trans-AAPF but does not entirely preclude cis-AAPF binding, we hypothesized that photocontrol of AAPF could be utilized to gain selective control of suppressor tRNA acylation and therefore control protein yield using irradiation.

Figure 4.

Figure 4

Computational analysis of cis- vs trans-AAFP in AzoFRS2. Effects of cis-AAPF (yellow) and trans-AAPF (cyan) on AzoFRS2 residues (A) F349, (B) G313, and (C) W382 and G368. (D) Differences in Rosetta energies for AzoFRS2 active site residues when docked with either cis- or trans-AAPF.

Recognition of trans- versus cis-AAPF by AzoFRS2 was then tested in bacterial cells (Figure 5A). The same two-plasmid expression system used to test AAPF incorporation in bacterial cells above was used to compare the incorporation of cis- vs trans-AAPF by AzoFRS2 via western blot analysis. E. coli cells transformed with pBAD-sfGFP-Y151TAG were treated with either cis- or trans-AAPF (1 mM, pre-irradiated with either 365 or 530 nm light, respectively), and then protein expression was induced by arabinose. After an overnight incubation, each culture was analyzed by anti-His western blot to visualize expression of sfGFP-Y151AAPF. Interestingly, complete background incorporation of cis-AAPF was observed in this experiment (Figure S4). We hypothesized that this observed background may be due to reversion to the trans-isomer over the long incubation period.

Figure 5.

Figure 5

Photocontrol of translation using AAPF. (A) Schematic representation of selective recognition of trans-AAPF by AzoFRS2 with corresponding computationally determined PylRS structures. (B) Western blot analysis of sfGFP-Y151AAPF expressed in E. coli cells treated with either cis-AAPF (irradiated with 365 nm every hour), cis-AAPF immediately irradiated with 530 nm, or trans-AAPF. (C) Quantification of western blot data from biological triplicates, where error bars represent standard deviation. Statistical analysis done via one-way ANOVA with multiple comparisons to the DMSO control, where n.s. = p = 0.1419, ***p ≤ 0.0001, and ****p ≤ 0.001.

To maintain the specified isomer throughout the course of the expression, a subset of the cis-AAPF-treated cultures were removed from the incubator and irradiated with the 365 nm light for 5 min every hour for 6 h after induction. To demonstrate control of translation, a subset of cis-AAPF-treated cultures were irradiated with 530 nm light (5 min) immediately after induction. After a total induction time of 6 h, each culture was analyzed by anti-His western blot to visualize expression of sfGFP-Y151AAPF (Figure 5B,C and Figure S5). While treatment with cis-AAPF alone does show background translation, short intervals of irradiation with 365 nm light throughout the total time of expression completely eliminate any observed background. Further, when treated with trans-AAPF, a strong mRNA translation response is observed, suggesting selective recognition of trans-AAPF by AzoFRS2.

Limited Stability of cis-AAPF

While the observed selectivity for trans-AAPF with regularly pulsed irradiations validated our computational predictions, we further investigated the initially observed background incorporation observed in cis-AAPF-treated cells during longer incubation periods. We found that the thermal stability of cis-AAPF is affected by the solvent, as decreased thermal stability was observed in acetonitrile, showing a t1/2 of 2.5 h, but stability was improved in PBS to a t1/2 of 36 h (Figure S3). The stability of cis-AAPF was then monitored in LB broth and FluoroBrite media (Figure 6A,D, respectively) to more closely mimic protein expression conditions. FluoroBrite media was used as an alternative to typical DMEM to prevent phenol red interference with the absorbance spectra. For each cis-AAPF stability test, a solution of AAPF (250 μM) was prepared in the specified media and then irradiated with 365 nm light for 10 min to reach the cis PSS. Each sample was then analyzed by an absorbance scan every 30 min for the first 4 h and then every 2 h after irradiation for a total of 24 h. Over the full 24 h, a considerable thermal isomerization back to the trans-isomer was observed, as the intensity at 340 nm continued to increase. By plotting the absorbance at 340 nm over time, the half-lives of 21 and >24 h were determined for cis-AAPF in LB broth and FluoroBrite media, respectively (Figure 6C,F). These extended half-lives suggested that the media alone is not contributing to the observed instability of the cis-isomer.

Figure 6.

Figure 6

Thermal stability of cis-AAPF. Absorbance spectra of cis-AAPF in (A) LB broth, (B) LB broth supplemented with 10 mM GSH, (D) FluoroBrite media, or (E) FluoroBrite media supplemented with 10 mM reduced glutathione, measured in triplicate over 24 h. Change in absorbance at 340 nm (trans-AAPF λmax) was plotted over time for (C) LB +/– GSH and (F) FB +/– GSH, and respective t1/2 values were determined for each condition.

For further investigation into cis-AAPF stability, its sensitivity to thiol reduction, and subsequent isomerization back to trans-AAPF, was analyzed. Azobenzenes are known to undergo reduction by thiols,46,47 so we tested cis-AAPF stability in the presence of glutathione (GSH), which persists in cellular environments between 0.5 and 10 mM.46 To mimic both bacterial and mammalian expression conditions, LB broth and FluoroBrite media were supplemented with 10 mM reduced glutathione, and cis-AAPF stability was monitored by the absorbance spectra (Figure 6B,E, respectively). The presence of the thiol led to much faster relaxation of cis-AAPF back to trans-AAPF in both LB broth and FluoroBrite media. From the collected absorbance spectra, cis-AAPF half-lives of 30 min and 2.75 h were determined in LB broth and FluoroBrite media, respectively (Figure 6C,F). Overall, the thermal isomerization of cis-AAPF in either media with glutathione is fast enough that a percentage of trans-AAPF will likely be formed during the duration of a typical protein expression. Because the trans-isomer is recognized by AzoFRS2 and expressions usually occur over several hours, the thermal relaxation of cis-AAPF back to trans-AAPF in our initial experiment was likely the cause of the observed background translation. We cannot rule out that some cis-AAPF may be accepted as a substrate by AzoFRS2, although it is unlikely, as the addition of regularly pulsed irradiations throughout the time of expression is sufficient to eliminate background UAA incorporation.

Conclusions

A photoswitchable phenylalanine derivative, arylazopyrazole phenylalanine (AAPF), was synthesized, and its photochemical properties were characterized. AAPF reaches its trans photostationary state after 10 min of irradiation at 530 nm. When irradiated with 365 nm light for 10 min, the cis photostationary state is reached, yielding an absorbance spectrum with decreased π–π* absorbance at 340 nm and increased n−π* absorbance at 436 nm. The quantification of each photostationary state validates near-complete isomerization, with 96% trans-AAPF and 91% cis-AAPF observed after respective irradiations. Further, the reversible isomerization of AAPF was demonstrated through sequential irradiations and characterization of the resultant isomer. To genetically encode this photoswitch, a tRNA synthetase panel screen revealed a PylRS, previously termed as AzoFRS2, that efficiently incorporated the amino acid into proteins in both bacterial and mammalian cells. Through molecular modeling, selective incorporation of trans-AAPF by AzoFRS2 was rationalized and experimental tests demonstrated a distinct preference for trans-AAPF over the cis-isomer. This enabled optical control of translation of a gene of interest through the simple introduction of AAPF at an amber stop codon. While background activity was observed over time due to thermal reversion of the cis-isomer, simple addition of regularly pulsed irradiations throughout the course of the experiment eliminated background translation. Overall, this UAA shows promise as a reversible translational switch for photocontrol of gene expression. In future studies, we intend to investigate AAPF as an optical switch of protein function.

Acknowledgments

We thank the National Institute of Health (grant number R01GM132565) for support.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.3c03512.

  • Synthetic protocols; NMR and MS characterizations; photochemical analysis protocols and results; biological protocols including synthetase screening, AAPF incorporation in bacterial and mammalian cells, live cell imaging, and western blots; computational protocols; thermal stability of cis-AAPF (PDF)

Author Contributions

# C.P.J., O.S., and T.M.C. contributed equally to this work.

Author Contributions

T.M.C. and C.P.J. performed biological assays. T.M.C. and O.S. performed photochemical analyses. T.J.H., C.P.J., and O.S. contributed to the synthesis. M.L. performed the computational modeling. A.D., S.D.K., C.P.J., and O.S. wrote the manuscript.

The authors declare no competing financial interest.

Supplementary Material

ao3c03512_si_001.pdf (324KB, pdf)

References

  1. Fenno L.; Yizhar O.; Deisseroth K. The development and application of optogenetics. Annu. Rev. Neurosci. 2011, 34, 389–412. 10.1146/annurev-neuro-061010-113817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Airan R. D.; Thompson K. R.; Fenno L. E.; Bernstein H.; Deisseroth K. Temporally precise in vivo control of intracellular signalling. Nature 2009, 458, 1025–1029. 10.1038/nature07926. [DOI] [PubMed] [Google Scholar]
  3. Toettcher J. E.; Weiner O. D.; Lim W. A. Using Optogenetics to Interrogate the Dynamic Control of Signal Transmission by the Ras/Erk Module. Cell 2013, 155, 1422–1434. 10.1016/j.cell.2013.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Tabor J. J.; Levskaya A.; Voigt C. A. Multichromatic Control of Gene Expression in Escherichia coli. J. Mol. Biol. 2011, 405, 315–324. 10.1016/j.jmb.2010.10.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cao J.; Arha M.; Sudrik C.; Kane R. S.; Bugaj L. J.; Schaffer D. V.. Characterization of an optogenetic translation activation system. In 2014 40th Annual Northeast Bioengineering Conference (NEBEC), 25–27 April 2014, 2014; pp. 1–2.
  6. Benedetti L. Optogenetic Tools for Manipulating Protein Subcellular Localization and Intracellular Signaling at Organelle Contact Sites. Current Protocols 2021, 1, e71 10.1002/cpz1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Uchida A.; Yajima M. An optogenetic approach to control protein localization during embryogenesis of the sea urchin. Dev. Biol. 2018, 441, 19–30. 10.1016/j.ydbio.2018.06.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wu D. Z.; Lackner R. M.; Aonbangkhen C.; Lampson M. A.; Chenoweth D. M. Reversible optogenetic control of protein function and localization. In Methods in Enzymology, Deiters A. Ed.; Vol. 624; Academic Press, 2019; pp. 25–45. [DOI] [PubMed] [Google Scholar]
  9. Deiters A. Principles and applications of the photochemical control of cellular processes. ChemBioChem 2010, 11, 47–53. 10.1002/cbic.200900529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hoorens M. W. H.; Szymanski W. Reversible, Spatial and Temporal Control over Protein Activity Using Light. Trends Biochem. Sci. 2018, 43, 567–575. 10.1016/j.tibs.2018.05.004. [DOI] [PubMed] [Google Scholar]
  11. Lee H. N.; Mehta S.; Zhang J. Recent advances in the use of genetically encodable optical tools to elicit and monitor signaling events. Curr. Opin. Cell Biol. 2020, 63, 114–124. 10.1016/j.ceb.2020.01.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kneuttinger A. C. A guide to designing photocontrol in proteins: methods, strategies and applications. Biol. Chem. 2022, 403, 573–613. 10.1515/hsz-2021-0417. [DOI] [PubMed] [Google Scholar]
  13. Baker A. S.; Deiters A. Optical control of protein function through unnatural amino acid mutagenesis and other optogenetic approaches. ACS Chem. Biol. 2014, 9, 1398–1407. 10.1021/cb500176x. [DOI] [PubMed] [Google Scholar]
  14. O’Banion C. P.; Lawrence D. S. Optogenetics: A Primer for Chemists. ChemBioChem 2018, 19, 1201–1216. 10.1002/cbic.201800013. [DOI] [PubMed] [Google Scholar]
  15. Zhou W.; Wesalo J. S.; Liu J.; Deiters A. Genetic code expansion in mammalian cells: A plasmid system comparison. Bioorg. Med. Chem. 2020, 28, 115772 10.1016/j.bmc.2020.115772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chin J. W. Expanding and Reprogramming the Genetic Code of Cells and Animals. Annu. Rev. Biochem. 2014, 83, 379–408. 10.1146/annurev-biochem-060713-035737. [DOI] [PubMed] [Google Scholar]
  17. Willis J. C. W.; Chin J. W. Mutually orthogonal pyrrolysyl-tRNA synthetase/tRNA pairs. Nat. Chem. 2018, 10, 831–837. 10.1038/s41557-018-0052-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Meineke B.; Heimgärtner J.; Lafranchi L.; Elsässer S. J. Methanomethylophilus alvus Mx1201 Provides Basis for Mutual Orthogonal Pyrrolysyl tRNA/Aminoacyl-tRNA Synthetase Pairs in Mammalian Cells. ACS Chem. Biol. 2018, 13, 3087–3096. 10.1021/acschembio.8b00571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wan W.; Tharp J. M.; Liu W. R. Pyrrolysyl-tRNA synthetase: an ordinary enzyme but an outstanding genetic code expansion tool. Biochim. Biophys. Acta 2014, 1844, 1059–1070. 10.1016/j.bbapap.2014.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shandell M. A.; Tan Z.; Cornish V. W. Genetic Code Expansion: A Brief History and Perspective. Biochemistry 2021, 60, 3455–3469. 10.1021/acs.biochem.1c00286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Drienovská I.; Roelfes G. Expanding the enzyme universe with genetically encoded unnatural amino acids. Nat. Catal. 2020, 3, 193–202. 10.1038/s41929-019-0410-8. [DOI] [Google Scholar]
  22. Bose M.; Groff D.; Xie J.; Brustad E.; Schultz P. G. The Incorporation of a Photoisomerizable Amino Acid into Proteins in E. coli. J. Am. Chem. Soc. 2006, 128, 388–389. 10.1021/ja055467u. [DOI] [PubMed] [Google Scholar]
  23. Padilla M. S.; Young D. D. Photosensitive GFP mutants containing an azobenzene unnatural amino acid. Bioorg. Med. Chem. Lett. 2015, 25, 470–473. 10.1016/j.bmcl.2014.12.035. [DOI] [PubMed] [Google Scholar]
  24. Luo J.; Samanta S.; Convertino M.; Dokholyan N. V.; Deiters A. Reversible and Tunable Photoswitching of Protein Function through Genetic Encoding of Azobenzene Amino Acids in Mammalian Cells. ChemBioChem 2018, 19, 2178–2185. 10.1002/cbic.201800226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hoppmann C.; Maslennikov I.; Choe S.; Wang L. In Situ Formation of an Azo Bridge on Proteins Controllable by Visible Light. J. Am. Chem. Soc. 2015, 137, 11218–11221. 10.1021/jacs.5b06234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hoppmann C.; Lacey V. K.; Louie G. V.; Wei J.; Noel J. P.; Wang L. Genetically Encoding Photoswitchable Click Amino Acids in Escherichia coli and Mammalian Cells. Angew. Chem., Int. Ed. 2014, 53, 3932–3936. 10.1002/anie.201400001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zimmerman G.; Chow L.-Y.; Paik U.-J. The Photochemical Isomerization of Azobenzene1. J. Am. Chem. Soc. 1958, 80, 3528–3531. 10.1021/ja01547a010. [DOI] [Google Scholar]
  28. Wendler T.; Schütt C.; Näther C.; Herges R. Photoswitchable Azoheterocycles via Coupling of Lithiated Imidazoles with Benzenediazonium Salts. J. Org. Chem. 2012, 77, 3284–3287. 10.1021/jo202688x. [DOI] [PubMed] [Google Scholar]
  29. Travieso-Puente R.; Budzak S.; Chen J.; Stacko P.; Jastrzebski J. T. B. H.; Jacquemin D.; Otten E. Arylazoindazole Photoswitches: Facile Synthesis and Functionalization via SNAr Substitution. J. Am. Chem. Soc. 2017, 139, 3328–3331. 10.1021/jacs.6b12585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Calbo J.; Weston C. E.; White A. J. P.; Rzepa H. S.; Contreras-García J.; Fuchter M. J. Tuning Azoheteroarene Photoswitch Performance through Heteroaryl Design. J. Am. Chem. Soc. 2017, 139, 1261–1274. 10.1021/jacs.6b11626. [DOI] [PubMed] [Google Scholar]
  31. Szymański W.; Beierle J. M.; Kistemaker H. A. V.; Velema W. A.; Feringa B. L. Reversible Photocontrol of Biological Systems by the Incorporation of Molecular Photoswitches. Chem. Rev. 2013, 113, 6114–6178. 10.1021/cr300179f. [DOI] [PubMed] [Google Scholar]
  32. Peddie V.; Abell A. D. Photocontrol of peptide secondary structure through non-azobenzene photoswitches. J. Photochem. Photobiol., C 2019, 40, 1–20. 10.1016/j.jphotochemrev.2019.05.001. [DOI] [Google Scholar]
  33. Stricker L.; Böckmann M.; Kirse T. M.; Doltsinis N. L.; Ravoo B. J. Arylazopyrazole Photoswitches in Aqueous Solution: Substituent Effects, Photophysical Properties, and Host–Guest Chemistry. Chem. – Eur. J. 2018, 24, 8639–8647. 10.1002/chem.201800587. [DOI] [PubMed] [Google Scholar]
  34. Devi S.; Saraswat M.; Grewal S.; Venkataramani S. Evaluation of Substituent Effect in Z-Isomer Stability of Arylazo-1H-3,5-dimethylpyrazoles: Interplay of Steric, Electronic Effects and Hydrogen Bonding. J. Org. Chem. 2018, 83, 4307–4322. 10.1021/acs.joc.7b02604. [DOI] [PubMed] [Google Scholar]
  35. Akahoshi A.; Doi Y.; Sisido M.; Watanabe K.; Ohtsuki T. Photo-dependent protein biosynthesis using a caged aminoacyl-tRNA. Bioorg. Med. Chem. Lett. 2014, 24, 5369–5372. 10.1016/j.bmcl.2014.10.053. [DOI] [PubMed] [Google Scholar]
  36. Ohtsuki T.; Kanzaki S.; Nishimura S.; Kunihiro Y.; Sisido M.; Watanabe K. Phototriggered protein syntheses by using (7-diethylaminocoumarin-4-yl)methoxycarbonyl-caged aminoacyl tRNAs. Nat. Commun. 2016, 7, 12501. 10.1038/ncomms12501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Zhang D.; Jin S.; Piao X.; Devaraj N. K. Multiplexed Photoactivation of mRNA with Single-Cell Resolution. ACS Chem. Biol. 2020, 15, 1773–1779. 10.1021/acschembio.0c00205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Klöcker N.; Weissenboeck F. P.; van Dülmen M.; Śpaček P.; Hüwel S.; Rentmeister A. Photocaged 5′ cap analogues for optical control of mRNA translation in cells. Nat. Chem. 2022, 14, 905–913. 10.1038/s41557-022-00972-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Ogasawara S. Control of Cellular Function by Reversible Photoregulation of Translation. ChemBioChem 2014, 15, 2652–2655. 10.1002/cbic.201402495. [DOI] [PubMed] [Google Scholar]
  40. Ogasawara S. Duration Control of Protein Expression in Vivo by Light-Mediated Reversible Activation of Translation. ACS Chem. Biol. 2017, 12, 351–356. 10.1021/acschembio.6b00684. [DOI] [PubMed] [Google Scholar]
  41. Schwanhäusser B.; Busse D.; Li N.; Dittmar G.; Schuchhardt J.; Wolf J.; Chen W.; Selbach M. Global quantification of mammalian gene expression control. Nature 2011, 473, 337–342. 10.1038/nature10098. [DOI] [PubMed] [Google Scholar]
  42. Rabani M.; Levin J. Z.; Fan L.; Adiconis X.; Raychowdhury R.; Garber M.; Gnirke A.; Nusbaum C.; Hacohen N.; Friedman N.; et al. Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat. Biotechnol. 2011, 29, 436–442. 10.1038/nbt.1861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Yang Y.; Wang L.; Han X.; Yang W. L.; Zhang M.; Ma H. L.; Sun B. F.; Li A.; Xia J.; Chen J.; et al. RNA 5-Methylcytosine Facilitates the Maternal-to-Zygotic Transition by Preventing Maternal mRNA Decay. Mol. Cell 2019, 75, 1188–1202.e11. 10.1016/j.molcel.2019.06.033. [DOI] [PubMed] [Google Scholar]
  44. Englert M.; Nakamura A.; Wang Y.-S.; Eiler D.; Söll D.; Guo L.-T. Probing the active site tryptophan of Staphylococcus aureus thioredoxin with an analog. Nucleic Acids Res. 2015, 43, 11061–11067. 10.1093/nar/gkv1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Qianzhu H.; Welegedara A. P.; Williamson H.; McGrath A. E.; Mahawaththa M. C.; Dixon N. E.; Otting G.; Huber T. Genetic Encoding of para-Pentafluorosulfanyl Phenylalanine: A Highly Hydrophobic and Strongly Electronegative Group for Stable Protein Interactions. J. Am. Chem. Soc. 2020, 142, 17277–17281. 10.1021/jacs.0c07976. [DOI] [PubMed] [Google Scholar]
  46. Boulègue C.; Löweneck M.; Renner C.; Moroder L. Redox Potential of Azobenzene as an Amino Acid Residue in Peptides. ChemBioChem 2007, 8, 591–594. 10.1002/cbic.200600495. [DOI] [PubMed] [Google Scholar]
  47. Beharry A. A.; Wong L.; Tropepe V.; Woolley G. A. Fluorescence Imaging of Azobenzene Photoswitching In Vivo. Angew. Chem., Int. Ed. 2011, 50, 1325–1327. 10.1002/anie.201006506. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ao3c03512_si_001.pdf (324KB, pdf)

Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES